[Neurofibromatosis--new clinical and molecular genetic aspects]
- PMID: 1678737
[Neurofibromatosis--new clinical and molecular genetic aspects]
Abstract
Neurofibromatosis is not a single entity. Seven types of the disorder are now known, which can be differentiated by clinical and genetic features. The wide variety of clinical manifestations makes close interdisciplinary cooperation necessary, in which the dermatologist frequently has a key role. The most frequent forms are peripheral neurofibromatosis (NF1) and central neurofibromatosis (NF2), for which separate gene localizations have been found on chromosomes 17 and 22, respectively, by molecular genetics techniques. The meanwhile possible prenatal diagnosis raises ethical questions.
Similar articles
-
[Neurofibromatosis: current clinical and molecular genetic aspects from the neurologic viewpoint].Nervenarzt. 1991 Jun;62(6):340-8. Nervenarzt. 1991. PMID: 1678877 Review. German.
-
Progress towards the isolation and characterization of the genes causing neurofibromatosis.Cancer Surv. 1990;9(4):689-702. Cancer Surv. 1990. PMID: 2129297 Review.
-
Neurofibromatosis 2 (bilateral acoustic schwannomas). What is it? A review of literature and an update.J Postgrad Med. 1992 Jan-Mar;38(1):27-31. J Postgrad Med. 1992. PMID: 1512722 Review. No abstract available.
-
[Neurofibromatosis; genetic and clinical aspects].Ned Tijdschr Geneeskd. 1989 Nov 18;133(46):2279-83. Ned Tijdschr Geneeskd. 1989. PMID: 2511452 Review. Dutch. No abstract available.
-
Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22.Nature. 1987 Sep 17-23;329(6136):246-8. doi: 10.1038/329246a0. Nature. 1987. PMID: 2888021
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous